Aptamer Group has secured two new development contracts and a licensing agreement to expand its Optimer platform’s applications in enzyme modulation and small molecule recognition.

Sapient, has launched the next generation of its multi-omics and real-world data (RWD) human biology database, now branded as the DynamiQ™ Insights Engine.

Leica Microsystems, has launched the Visoria series of upright microscopes, to help enhance the efficiency and comfort of routine microscopy work for pathologists, quality control managers and researchers.

Thailand is launching Asia’s first newborn genome screening pilot using PacBio HiFi whole genome sequencing.

Aptamer Group plc is pleased to announce the successful adaptation of the Optimer-based test for Alzheimer’s disease into an Enzyme-Linked Immunosorbent Assay (ELISA).

Eppendorf’s new 4-channel epMotion tools improve liquid transfer speed in tubes, boosting lab efficiency up to 4x.

Biodesix, in partnership with Bio-Rad, contributed to the ctMoniTR Project, which demonstrated that changes in circulating tumor DNA (ctDNA) can predict cancer treatment outcomes.

A new study highlights IsoPSA’s ability to identify low-risk prostate cancer patients who can avoid unnecessary interventions. The test also helps monitor high-risk patients more closely.

Bruker expands its microbiology solutions with new NGS-based tools for hospital infection tracking and epidemiology, in collaboration with Ridom GmbH.

Azenta Life Sciences' 4titude® PCR plates are optimized to enhance PCR and qPCR workflows, ensuring reliable and reproducible results.